Electrolyte Replacement - Critical Care ICU/PCU [ ] Protocol DATE/TIME PROVIDER INITIALS PHYSICIAN ORDERS. Height Weight Allergies
|
|
- Malcolm Blankenship
- 7 years ago
- Views:
Transcription
1 Electrolyte Replacement - Critical Care Height Weight Allergies If serum creatinine greater than 2mg/dL and/or documentation of renal failure or dialysis, RN will contact physician for specific replacement orders. Consult pharmacist at Highline hospital. Protocol Electrolyte Protocol [X] Electrolyte Protocol [X] Electrolyte Replacement Protocol: Critical Care (ICU/PCU) [X] Potassium [X] Calcium, ionized [X] Magnesium [X] Phosphorus RN to order specific medication needed based on lab result. If creatinine greater than 2 mg/dl and/or documentation of Renal Failure or Dialysis, contact physician for specific replacement orders. Use ORAL when able. If multiple electrolytes to be replaced, please consult pharmacist. PRN. Check level 1 hour post infusion or 4 hours after oral dose(s) and replace per order. PRN. Check level 2 hour post infusion or 4 hours after oral dose(s) and replace per order. PRN. Check level 2 hour post infusion or 4 hours after oral dose(s) and replace per order. PRN. Check level 2 hour post 50 meq IV infusion and replace per order. Check level in AM after ORAL or 20 meq or 30 meq IV infusion and replace per orders. Highline Only Pharmacy Consult for patients with SCr >=2, renal failure, or receiving dialysis. [ ] Highline Only Pharmacy Consult for Electrolyte Replacement, Once, Starting today Page 1 of 7
2 Potassium Replacement If serum creatinine over 2 mg /dl and/or Documentation of Renal failure or Dialysis, contact MD for specific orders. POTASSIUM LEVEL (Single Response) ( ) potassium ORAL tablet 40 meq, Oral, Once, For 1 Doses For Potassium level mmol/l ( ) potassium ORAL liquid 40 meq, Oral, Once, For 1 Doses For Potassium level mmol/l ( ) potassium CENTRAL IV 40 meq, IntraVENous, for 2 Hours, Once, Starting today, For 1 Doses For Potassium level mmol/l ( ) potassium PERIPHERAL IV 40 meq, IntraVENous, for 4 Hours, Once, For 1 Doses 40 meq for Potassium level mmol/l POTASSIUM LEVEL (Single Response) ( ) potassium ORAL tablet 40 meq, Oral, Every 2 hours, For 2 Doses For Potassium level mmol/l ( ) potassium ORAL liquid 40 meq, Oral, Every 2 hours, For 2 Doses For Potassium level mmol/l ( ) potassium CENTRAL IV 40 meq, IntraVENous, for 2 Hours, Every 2 hours, Starting today, For 2 Doses For Potassium level mmol/l ( ) potassium PERIPHERAL IV 40 meq, IntraVENous, for 4 Hours, Every 4 hours interval, For 2 Doses 40 meq for Potassium level mmol/l Page 2 of 7
3 POTASSIUM LEVEL LESS THAN 2.2 (Single Response) ( ) potassium CENTRAL IV 40 meq, IntraVENous, for 2 Hours, Every 2 hours, Starting today, For 2 Doses For Potassium level less than 2.2 mmol/l and notify MD if symptomatic. ( ) potassium PERIPHERAL IV 40 meq, IntraVENous, for 4 Hours, Every 2 hours, For 2 Doses 40 meq for Potassium level less than 2.2 mmol/l and notify MD if symptomatic. Page 3 of 7
4 Magnesium Replacement If serum creatinine over 2 mg /dl and/or Documentation of Renal failure or Dialysis, contact MD for specific orders. MAGNESIUM LEVEL (Single Response) ( ) magnesium ORAL liquid 30 ml, Oral, Daily as needed, other, give MOM or Magnesium oxide tablets once for Magnesium level mg/dl For Magnesium level mg/dl Recheck level 4 hours after oral dose and replace per order. ( ) magnesium ORAL tablet 800 mg, Oral, Once, For 1 Doses For Magnesium level mg/dl Recheck level 4 hours after oral dose and replace per order. ( ) magnesium IV 2 g, IntraVENous, for 0.5 Hours, Once, For 1 Doses For Magnesium level mg/dl Recheck level 2 hours post infusion and replace per orders. MAGNESIUM LEVEL LESS THAN 1.4 (Single Response) ( ) magnesium IV 4 g, IntraVENous, for 1 Hours, Once, For 1 Doses For Magnesium level less than 1.4 mg/dl Recheck level 2 hours post infusion and replace per orders. Page 4 of 7
5 Calcium Replacement If serum creatinine over 2 mg/dl and/or Documentation of Renal failure or Dialysis, contact MD for specific orders. Ionized CALCIUM LEVEL (Single Response) ( ) calcium ORAL 1,250 mg, Oral, Every 4 hours interval, First Dose Today, For 2 Doses For ionized Calcium level mmol/l 1250 mg calcium carbonate (equivalent to 500mg elemental calcium). ( ) calcium CENTRAL IV 1 g, IntraVENous, for 10 Minutes, Once, For 1 Doses For ionized Calcium level mmol/l If calcium chloride not available, pharmacist will change order to calcium gluconate 3 g over 1 hour once. Do NOT infuse in HAND or Small Veins. Do NOT infuse in same line WITH potassium or sodium PHOSPHATE, Max 200 mg (1mEq)/min ( ) calcium PERIPHERAL IV 3 g, IntraVENous, for 1 Hours, Once, For 1 Doses For ionized Calcium level mmol/l If calcium gluconate not available, pharmacist will change order to calcium chloride 1 g/50 ml over 1 hour once. Ionized CALCIUM LEVEL LESS THAN 1 (Single Response) ( ) calcium CENTRAL IV 2 g, IntraVENous, for 30 Minutes, Once, For 1 Doses For ionized Calcium level less than 1 mmol/l If calcium chloride not available, pharmacist will change order to calcium gluconate 3 g every 1 hour for 2 doses. Do NOT infuse in HAND or Small Veins. Do NOT infuse in same line WITH potassium or sodium PHOSPHATE, Max 200 mg (1mEq)/min ( ) calcium PERIPHERAL IV 3 g, IntraVENous, for 1 Hours, Every 1 hour, For 2 Doses For ionized Calcium level less than 1 mmol/l If calcium gluconate not available, pharmacist will change order to calcium chloride 2 g/50 ml over 1 hour once. Page 5 of 7
6 Phosphate Replacement If serum creatinine over 2 mg /dl and/or Documentation of Renal failure or Dialysis, contact MD for specific orders. PHOSPHORUS LEVEL (Single Response) ( ) Phosphate ORAL 2 packet, Oral, Every 2 hours, For 2 Doses For Phosphorus level mg/dl ( ) Phosphate CENTRAL IV 20 meq, IntraVENous, for 4 Hours, Once, For 1 Doses For Phosphorus level mg/dl ( ) Phosphate PERIPHERAL IV 20 meq, IntraVENous, for 4 Hours, Once, For 1 Doses For Phosphorus level mg/dl PHOSPHORUS LEVEL (Single Response) ( ) Phosphate IV 35 meq, IntraVENous, for 4 Hours, Once, For 1 Doses For Phosphorus level mg/dl PHOSPHORUS LEVEL LESS THAN 1 (Single Response) ( ) Phosphate IV 50 meq, IntraVENous, for 6 Hours, Once, For 1 Doses For Phosphorus level less than 1 mg/dl Date / Time Print Provider Name Provider Signature Date/Time RN Signature Acknowledgement Page 6 of 7
7 Page 7 of 7
Potassium Replacement
Potassium Replacement ** Always look at phosphorus level to determine appropriate potassium product ** K < 4.0 Phos > 2.5 Phos 2.5 Give KCl Give K Phos See Phos Protocol (additional KCl may be warranted)
More informationGeneral PROVIDER INITIALS: PHYSICIAN ORDERS
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 General Vital Signs
More informationHow To Treat An Alcoholic Patient
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 Discontinue all lorazepam
More information[ ] POCT glucose Routine, As needed, If long acting insulin is given and patient NPO, do POCT glucose every 2 hours until patient eats.
Glycemic Control - Insulin Infusion NOTE: For treatment of Diabetic Ketoacidosis or Hyperglycemic Hyperosmolar Syndrome please go to order set named Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar
More informationElectronic Medication Administration Record (emar) (For Cerner Sites Only)
POLICY NO. 1009 Approved: 12/05 Effective: 12/05 Reviewed: 9/10; 5/12 1. Purpose: Electronic Medication Administration Record (emar) (For Cerner Sites Only) To provide direction for the transcription and
More informationCARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy
Page 1 of 5 INDICATIONS EXCLUSIONS 2 consecutive blood glucose measurements greater than 110 mg per dl AND NPO with a continuous caloric source AND Diagnosis of : Cardio-thoracic Surgery NOTE: This protocol
More informationPATIENT PRESENTATION TREATMENT MONITORING/FOLLOW UP. Observation, normal hydration and monitoring. Low Risk 1
PATIENT PRESENTATION This practice algorithm has been specifically developed for M. D. Anderson using a multidisciplinary approach and taking into consideration circumstances particular to M. D. Anderson,
More informationSECTION: NM NUMBER: 20. HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs
CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/,
More informationProvision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine
Provision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine Guideline Updated: August 2010 Replaced: November 1998 To serve the public and guide the medical profession EDTA Chelation
More informationELECTROLYTE SOLUTIONS (Continued)
ELECTROLYTE SOLUTIONS (Continued) Osmolarity Osmotic pressure is an important biologic parameter which involves diffusion of solutes or the transfer of fluids through semi permeable membranes. Per US Pharmacopeia,
More informationPPP 1. Continuation of a medication to ensure continuity of care
PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The
More informationChronic Obstructive Pulmonary Disease (COPD) Admission Order Set
Patient Name: PHN: Page 1/1 Admit to Dr: Notified Consult: Dr: Family Dr: Precautions: Contact Droplet Enhanced Droplet Airborne - Reason: _ Code Status: Full Resuscitation or Consults: Reason: Dietician
More informationPHYSICIAN ORDERS / PROGRESS NOTES
PHYSICIAN / PROGRESS NOTES Drs Joseph Thibodeau and Louis Violi Created: 4/10 - Next Review: 4/10 Page 1 of 5 Initiation Phase: Emergency Department Notify Interventional Cardiology and Cath Lab immediately
More informationCyclophosphamide/Rabbit Anti-Thymocyte Globulin for Allograft
INDICATIONS Cyclophosphamide/Rabbit Anti-Thymocyte Globulin for Allograft Aplastic Anaemia (patients under 40 years) PRE-ASSESSMENT Ensure pre-transplant work-up form is complete Ensure patient has triple
More informationDrug Shortage Alert 11/15/2012
Drug Shortage Alert 11/15/2012 Recommendations and information provided in Drug Shortage Alerts are compiled by experts in the field. Practitioners always are advised to consult with staff to ensure response
More informationReducing Medication Risks of Electronic Medication Systems
Program Date: August 10, 2012 Geriatric Grand Rounds Topic: Reducing Medication Risks of Electronic Medication Systems Presenter: Laura Finn, CGP, FASCP, Consultant Pharmacist Adjunct Associate Professor
More informationDATE / TIME PROVIDER INITIALS PHYSICIAN ORDERS
If appropriate for this patient, please consider the following order sets: Heart Failure Addendum #609; Acute COPD #789, Glycemic Control - Insulin Infusion #824, Glycemic Control - Subcutaneous Addendum
More informationSLIDING SCALE INSULIN ASPART PROTOCOL PLAN
Weight Allergies Patient Care Accucheck Per Sliding Scale Insulin Frequency AC & HS AC & HS 3 days TID BID q12h q6h q6h 24 hr q4h q2h Sliding Scale Insulin Protocol Follow SSI Reference Text Medications
More informationQuiz 5 Heart Failure scores (n=163)
Quiz 5 Heart Failure summary statistics The correct answers to questions are indicated by *. Students were awarded 2 points for question #3 for either selecting spironolactone or eplerenone. However, the
More informationSLIDING SCALE INSULIN REGULAR PLAN
PHYSICIAN S Weight Allergies DETAILS Patient Care POC Blood Sugar Check Per Sliding Scale Insulin Frequency AC & HS AC & HS 3 days TID BID q12h q6h q6h 24 hr q4h q2h Sliding Scale Insulin Regular Guidelines
More informationPREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)
ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase
More informationPHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION
SCREENING- ABCD-2 Score The ABCD2 score is a risk assessment tool designed to improve the prediction of short-term stroke risk after a transient ischemic attack (TIA). Higher ABCD2 scores are associated
More informationD( desired ) Q( quantity) X ( amount ) H( have)
Name: 3 (Pickar) Drug Dosage Calculations Chapter 10: Oral Dosage of Drugs Example 1 The physician orders Lasix 40 mg p.o. daily. You have Lasix in 20 mg, 40 mg, and 80 mg tablets. If you use the 20 mg
More informationContinuous Renal Replacement Therapy. Jai Radhakrishnan, MD, MS
Continuous Renal Replacement Therapy Jai Radhakrishnan, MD, MS History of the CRRT program 1988 Open heart program Active transplant program Deep dissatisfaction with peritoneal dialysis in hemodynamically
More informationReplacement post-filter (ml/hr) Blood flow (ml/min) Dialysate (ml/hr) Weight (kg)
404FM.1 CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) USING CITRATE Target Audience: Hospital only ICU (Based on Gambro and Kalmar Hospital protocols) CRRT using regional citrate anticoagulation This is
More informationHydration Protocol for Cisplatin Chemotherapy
Betsi Cadwaladr University Health Version: 1.3 CSPM2 Hydration Protocol for Cisplatin Chemotherapy Date to be reviewed: July 2018 No of pages: 9 Author(s): Tracy Parry-Jones Author(s) title: Lead Cancer
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE CARE OF THE INTRAPARTUM PATIENT RECEIVING CONTINUOUS INTRAVENOUS INSULIN ADMINISTRATION (obs25) DATE: REVIEWED: PAGES: 9/93 8/15 1 of 7 PS1094 ISSUED
More informationInpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
More informationGeorgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR:
Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR: CLINICAL UNIT: ASSIGNMENT DATES: PATIENT (last initial):
More informationPackage leaflet: information for the user Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration Calcium chloride dihydrate/ magnesium chloride hexahydrate/ glucose monohydrate/ lactic
More informationTotal Parenteral Nutrition. Student Worksheet
Page # 1 Total Parenteral Nutrition Student Worksheet Purpose: Indications for use: Disadvantages: Components & Types of Solutions: Water Dextrose: Carbohydrates provided in this form. RDA: 50-100 grams/day
More information1 Manipulation of formulae and dilutions
1 Manipulation of formulae and dilutions This first chapter of questions is specifically designed to cover a range of numeracy skills. It will give the user further experience in the skills of addition,
More informationSuffolk County Community College School of Nursing NUR 133 ADULT NURSING I
Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Page # 1 Instructions for students: Case study # 1 For this lab, you are planning to provide care to the following client: CB
More informationNOTICES DEPARTMENT OF HEALTH
NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [43 Pa.B. 3060] [Saturday, June 1, 2013] Under 28 Pa. Code 1005.11 (relating to drug use, control and security), the following drugs
More informationMedication Calculation Practice Problems
1 Medication Calculation Practice Problems Dosage Calculation 1. The order is for 60 mg of furosemide (Lasix) po daily. Available to the nurse is Lasix 40 mg/tablet. The nurse would administer how many
More informationONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)
ADULT INSULIN PRERIPTION AND BLOOD GLUCOSE MONITORING CHART Ward CONSULTANT DATE OF ADMISSION Please affix Patient s label here Ward Ward.../...year PATIENT NAME....... DATE OF BIRTH... NHS NUMBER.......
More information(30251) Insulin SQ Prandial Carbohydrate
Diagnosis Patient MUST BE educated using carbohydrate counting for prial insulin coverage before hospitalization to be eligible for this order set Nursing Metered Glucose (Single Select Section) Metered
More informationOutpatient Anticoagulation Treatment Packet
Emergency / Pharmacy Services Outpatient Anticoagulation Treatment Packet Check when complete (If indicated): Primary Care Provider Follow Referral to Franciscan Transitional Clinic (if no primary care
More informationBasic Medication Administration Exam RN (BMAE-RN) Study Guide
Basic Medication Administration Exam RN (BMAE-RN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM, subcut injections
More informationCommunity Pharmacists in NHS Rotherham
SERVICE LEVEL AGREEMENT TO ENABLE COMMUNITY PHARMACISTS IN NHS ROTHERHAM TO PROVIDE PALLIATIVE CARE DRUGS AS LOCAL ENHANCED SERVICE PREPARED BY: NHS Rotherham CCG Medicines Management Team on behalf of
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
One Children s Plaza Dayton, OH 45404-1815 www.childrensdayton.org DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended
More informationHypoglycemia (Technician-Paramedic) Protocol revised October 2008
Hypoglycemia (Technician-Paramedic) Protocol revised October 2008 Preamble Prolonged hypoglycemia may result in serious neurologic complications and death. Glucose and glucagon can be administered to correct
More informationMEDICINES MANAGEMENT STANDARD OPERATING PROCEDURE (MMSOP018) Preparation of Medication Administration Record (MAR) Charts
MEDICINES MANAGEMENT STANDARD OPERATING PROCEDURE (MMSOP018) Preparation of Medication Administration Record (MAR) Charts Any deviation in practice from this procedure must be discussed with the Community
More informationDocetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer
Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer Background: A non-anthracycline based regimen for high-risk, HER 2 positive breast cancer in the adjuvant setting (BCIRG 006). Patient
More informationProduct Information: Osmolite 1.2 Cal
Product Information: Osmolite 1.2 Cal 1 of 5 OSMOLITE 1.2 CAL is a source of Complete, Balanced Nutrition and a high-protein, lowresidue formula for tube-fed patients who may benefit from increased protein
More information[ ] Cardiac monitoring Routine, Until discontinued, Starting today, PACU (only)
If appropriate for patient condition, please consider the following order sets: Hydration Order for Reducing Risk of Radiocontrast Induced Nephrotoxicity #683 Over the Counter Patient Care Products #767
More informationAcetylcysteine Inhalation Solution
Drug Shortage information Action Plan delays and another manufacturer voluntarily suspending production. Hospira has a limited supply available and other manufacturers are unable to estimate a release
More informationThe Role of Bisphosphonates in Multiple Myeloma: 2007 Update Clinical Practice Guideline
The Role of Bisphosphonates in Multiple Myeloma: 2007 Update Clinical Practice Guideline Introduction ASCO convened an Update Committee to review and update the 2002 recommendations for the role of bisphosphonates
More informationLung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC)
Indication: NICE TA181 First line treatment option in advanced or metastatic non-squamous NSCLC (histology confirmed as adenocarcinoma or large cell carcinoma) Performance status 0-1 Regimen details: Pemetrexed
More informationThe Eating Disorder Program The Hospital for Sick Children
The Eating Disorder Program Dear Doctor: Thank-you for your referral to the Eating Disorder Program at. The Eating Disorder Program at provides assessment and treatment for adolescents who suffer from
More informationProduct Information: PediaSure
Product Information: PediaSure 1 of 5 PEDIASURE is a source of Complete, Balanced Nutrition especially designed for the oral feeding of children 2 to 13 years of age. May be used as the sole source of
More informationUpstate University Health System Medication Exam - Version A
Upstate University Health System Medication Exam - Version A Name: ID Number: Date: Unit: Directions: Please read each question below. Choose the best response for each of the Multiple Choice and Medication
More informationREFERENCE. Admit to: Program/Service: Diagnosis: Droplet/ Contact Airborne/ Contact
Weight (kg) REFER TO THE ALLERGY SCREEN IN MEDITECH FOR ALLERGY INFORMATION To complete the order form, fill in the required blanks and/or check the appropriate boxes. To delete orders, draw one line through
More informationA Correct. The D in the order means dextrose which provides calories.
PRACTICE PROBLEMS Practice Problem 1: The order you have is: 1000mL D5NS q 12 h The patient will receive a large or small bag of fluid? Correct answer is a. a. Large b. Small B. Incorrect. 1000mL is a
More informationProduct Category: Osmolite
Osmolite Product Category: Osmolite Osmolite 1 Cal Osmolite 1.2 Cal Osmolite 1.5 Cal Updated 4/28/2016 Osmolite 1 Cal Isotonic Nutrition Product Information: Osmolite 1 Cal 1 of 4 Osmolite 1 Cal Isotonic
More informationCare Pathway for the Administration of Intravenous Iron Sucrose (Venofer )
Departments of Haematology, Nephrology and Pharmacy Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) [Care Pathway Review Date] Guidance for use This Care Pathway is intended
More informationOctober 15, 2010. Email: bcadotte@ocpinfo.com
October 15, 2010 Email: bcadotte@ocpinfo.com Ms. Barbara Cadotte Senior Policy Advisor Ontario College of Pharmacists 483 Huron Street Toronto ON M5R 2R4 Dear Ms. Cadotte: The Ontario Pharmacists' Association
More informationTOTAL PARENTERAL NUTRITION (TPN) Revised January 2013
TOTAL PARENTERAL NUTRITION (TPN) Revised January 2013 OBJECTIVES Definition Indications for TPN administration Composition of TPN solutions Access routes for TPN administration Monitoring TPN administration
More informationHow To Treat A Diabetic Coma With Tpn
GUIDELINES FOR TOTAL PARENTERAL NUTRITION (TPN) IN ADULT BONE MARROW TRANSPLANT PATIENTS TPN Indications TPN is indicated for any patient who is not expected to eat sufficiently for 3-5 days in severe
More informationINFORMATION FOR PATIENT. WARNINGS Using more than one enema in 24 hours can be harmful.
FLEET ENEMA, A SALINE LAXATIVE - ready-to-use squeeze bottle FLEET ENEMA EXTRA, A SALINE LAXATIVE - ready-to-use squeeze bottle FLEET PEDIA-LAX ENEMA, A SALINE LAXATIVE - ready-to-use squeeze bottle FLEET
More informationType Description Advantage Disadvantage. Available in large diameter Ease of insertion
FLUID THERAPY IN THE EQUINE Joanne Hardy, DVM, PhD, Diplomate ACVS Fluid administration for maintenance or replacement purposes is one of the mainstays of equine critical care, and should be readily and
More informationNational Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment
NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient
More informationClinical Laboratory Parameters for Crl:CD(SD) Rats. March, 2006. Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D.
Clinical Laboratory Parameters for Crl:CD(SD) Rats March, 2006 Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D. CHARLES RIVER LABORATORIES Clinical Laboratory Parameters
More informationGESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
GESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION A disorder characterised by hyperglycaemia first recognised during pregnancy due to increased insulin resistance
More informationElectronic copy to all appropriate staff Intranet Notification in Staff Focus Related Trust Policies (to be read in conjunction with)
Diabetes Management for Children and Young People undergoing Surgery (0-16 yrs) Clinical Guideline Register No: 10096 Status: Public Developed in response to: Updated national guidelines Contributes to
More informationPHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG
DRUG AND TREATMENT Condition/Status This powerplan is only intended for use in those patients having symptoms related to alcohol withdrawal. See DSM-IV-TR criteria listed in the Alcohol Withdrawal ICU
More informationProduct Information: Promote
Product Information: Promote 1 of 5 PROMOTE is a complete, balanced, very-high-protein formula for patients who need a higher proportion of calories from protein. It is ideal for patients with low caloric
More informationBRIEFING 7 LABELING DEFINITION
Page 1 of 10 BRIEFING 7 Labeling. This general chapter provides definitions and standards for labeling of official articles. Note that, as with compendial quality standards, labeling requirements also
More informationMolarity of Ions in Solution
APPENDIX A Molarity of Ions in Solution ften it is necessary to calculate not only the concentration (in molarity) of a compound in aqueous solution but also the concentration of each ion in aqueous solution.
More informationMedications or therapeutic solutions may be injected directly into the bloodstream
Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals
More informationSepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status
Patient exhibits two or more of the following SIRS criteria: Temperature greater than 38 o C (100.4 o F) or less SIRS than criteria 36 o C (96.8 o F) Heart Rate greater than 90 beats/minute Respiratory
More informationThe medical risk arises from a combination of the restrictive behaviours (food and in some cases fluid) and the compensatory behaviours.
www.eatingresearch.com from the Section of Eating Disorders at the Institute of Psychiatry and the Eating Disorders Unit at SLaM A GUIDE TO THE MEDICAL RISK ASSESSMENT FOR EATING DISORDERS by Professor
More informationProduct Information: Jevity 1.5 Cal
Product Information: Jevity 1.5 Cal 1 of 5 JEVITY 1.5 CAL is a calorically dense formula with a unique fiber blend that provides Complete, Balanced Nutrition. For tube feeding. For supplemental or sole-source
More informationSOP for Screening of Adult Chemotherapy Electronic Prescriptions
SOP for Screening of Adult Chemotherapy Electronic Prescriptions Contents The following steps should be followed in screening a chemotherapy prescription on ARIA: 1. Patient details 2 2. Patient medical
More information0.9% Sodium Chloride injection may be used in most cases.
Table 2. Alternatives to Heparin Sodium in Selected Situations 12-14 Situation Alternative Dose Maintain patency of peripheral venous catheters* 21-26 0.9% Sodium Chloride injection may be used in most
More informationPROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults
PROTOCOL NUMBER: 7 PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults THIS PROTOCOL APPLIES TO: UW Health Clinics: all adult outpatients with an active order for warfarin TARGET
More informationtips Children&Teenagers 1 DKA in Infants, Children, and Adolescents:
tips Top International Publications Selection Children&Teenagers 1 DKA in Infants, Children, and Adolescents: a Consensus Statement from the ADA 1 2 Can We Prevent Diabetic Ketoacidosis in Children? 2
More informationCardiac Arrest - Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008
Cardiac Arrest - Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008 Preamble Survival from cardiorespiratory arrest for patients who present with ventricular fibrillation
More informationReducing Insulin Related Errors in Patients Treated for Hyperkalemia
Reducing Insulin Related Errors in Patients Treated for Hyperkalemia Tan Tock Seng Hospital is an acute care general hospital with a 1,200 bed capacity The hospital addressed the problem of insulinrelated
More informationIAC 1/12/11 Nursing Board[655] Ch 6, p.1 CHAPTER 6 NURSING PRACTICE FOR REGISTERED NURSES/LICENSED PRACTICAL NURSES
IAC 1/12/11 Nursing Board[655] Ch 6, p.1 CHAPTER 6 NURSING PRACTICE FOR REGISTERED NURSES/LICENSED PRACTICAL NURSES 655 6.1(152) Definitions. Accountability means being obligated to answer for one s acts,
More informationCrash Cart Drugs Drugs used in CPR. Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University
Crash Cart Drugs Drugs used in CPR Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University Introduction A list of the drugs kept in the crash carts. This list has been approved by the
More informationProduct Information: Similac Human Milk Fortifier Hydrolyzed Protein Concentrated Liquid
Infant Formula with Extensively Hydrolyzed Protein Product Information: Similac Human Milk Fortifier Hydrolyzed Protein Concentrated 1 of 5 Infant Formula with Extensively Hydrolyzed Protein Extensively
More informationInpatient Pharmacy Order Processing. January 2012
Inpatient Pharmacy Order Processing January 2012 1 Learning Objectives Explain the difference between inpatient and outpatient medication orders Explain why inpatient and outpatient medication orders must
More informationBEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY RENAL BIOPSY
1 BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY GUIDELINES ON ADMINISTRATION OF INTRAVENOUS IRON SUCROSE (VENOFER) AS A BOLUS DOSE IN THE RENAL OUTPATIENT SETTING Date Developed: August- October 2007 RENAL
More informationPharmaceutical Waste Management Program St. Joseph Mercy Oakland. Pharmacy/Patient Care
Pharmaceutical Waste Management Program St. Joseph Mercy Oakland Pharmacy/Patient Care Objectives Understand the background and regulatory requirements Identify pharmaceutical waste and how to dispose
More informationNote that the following document is copyright, details of which are provided on the next page.
Please note that the following document was created by the former Australian Council for Safety and Quality in Health Care. The former Council ceased its activities on 31 December 2005 and the Australian
More informationProduct Information: Jevity 1.5 Cal
Product Information: Jevity 1.5 Cal 1 of 5 JEVITY 1.5 CAL is a calorically dense formula with a unique fiber blend that provides Complete, Balanced Nutrition. For tube feeding. For supplemental or sole-source
More informationLesson 2: Understanding expressions of drug amounts
Lesson 2: Understanding expressions of drug amounts All pharmaceutical preparations have some sort of ingredient amount associated with them, which many health care professionals refer to as strength.
More informationBeaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject
Beaumont Hospital Department of Nephrology and Renal Nursing Guideline Name: Guideline for administering Ferinject Guideline Number: 18 Guideline Version: a Developed By: Louise Kelly CNM 1 Renal Day Care
More informationInstructor Guide: CPOE (Order Entry) for the Nurse. Trainer Notes. Objective Learn about PowerPlans. Benefits of CPOE. Learn about Nurse Review
Instructor Guide: CPOE (Order Entry) for the Nurse Trainer Notes Section Name Duration Order Entry 45 minutes Objective Learn about PowerPlans Benefits of CPOE Learn about Nurse Review You ll Need Parking
More informationUse of the Injectable Medicines Guide website in clinical areas - IntraVENOUS medicine monographs (January 2013)
Use of the Injectable Medicines Guide website in clinical areas - IntraVENOUS medicine monographs (January 2013) Introduction The IntraVENOUS medicines section of the Injectable Medicines Guide website
More informationINSULIN-DEPENDENT DIABETES HEALTH CARE PLAN: II
INSULIN-DEPENDENT DIABETES HEALTH CARE PLAN: II DATE: SCHOOL: GRADE: STUDENT: BIRTHDATE: HOME ADDRESS: PARENT/GUARDIAN: PARENT S PHONE: Home: Mom s work: Dad s work: EMERGENCY CONTACT (NAME, NUMBER and
More informationLABORATORY and PATHOLOGY SERVICES
LABORATORY and PATHOLOGY SERVICES Policy Neighborhood Health Plan reimburses participating clinical laboratory and pathology providers for tests medically necessary for the diagnosis, treatment and prevention
More informationQuestions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV
Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV The purpose of this document is to provide additional clarification to the existing information
More informationSUFFOLK COUNTY COMMUNITY COLLEGE NURSING DEPARTMENT MEDICATION ADMINISTRATION TEST NR 40 Practice test questions READ INSTRUCTIONS CAREFULLY
NR40 MEDICATION MATH TEST Practice questions page 1 SUFFOLK COUNTY COMMUNITY COLLEGE NURSING DEPARTMENT MEDICATION ADMINISTRATION TEST NR 40 Practice test questions READ INSTRUCTIONS CAREFULLY Students
More informationElectronic Medical Record (EMR) Safety Results of CAH Testing. Tom Johns, PharmD Shands at the University of Florida
Electronic Medical Record (EMR) Safety Results of CAH Testing Tom Johns, PharmD Shands at the University of Florida Vendors Evaluated CPSI Healthland Cerner Test Patients Test Patient A Age: 76 y/o Sex:
More informationThe early symptoms of acute salicylism are the triad of gastrointestinal distress, tinnitus or altered hearing, and hyperventilation.
POISONING SALICYLATES (ASPIRIN) Management Guidelines Emergency Department Princess Margaret Hospital for Children Perth, Western Australia Last reviewed: January 2007 Page 1 of 5 Dr Gary Geelhoed Dr Frank
More informationProduct Information: Jevity 1.2 Cal
Product Information: Jevity 1.2 Cal 1 of 5 JEVITY 1.2 CAL is a high-protein, fiber-fortified formula that provides Complete, Balanced Nutrition for long- or short-term tube feeding. For tube feeding. For
More informationSchedule: Drug Dose iv/infusion/oral q Doxorubicin 25mg/m 2 iv bolus Days 1, 2 & 3 Cisplatin 50mg/m 2 1L N. Saline/2hrs Days 1 & 2
Doxorubicin/Cisplatin Osteosarcoma - neoadjuvant Doxorubicin 25mg/m 2 iv bolus Days 1, 2 & 3 Cisplatin 50mg/m 2 1L N. Saline/2hrs Days 1 & 2 (3 before surgery) Ensure adequate renal function Pre & post-hydration,
More informationSafe Medication Administration Preparation Guide C.O.R.E Essentials
Safe Medication Administration Preparation Guide C.O.R.E Essentials As a new IU Health employee, a portion of your orientation will focus on Safe Medication Administration practices. You will participate
More information